Antioxidants in cardiovascular disease: Randomized trials

Nutrition

Volumn 12, Issue 9, 1996, Pages 583-588

  Gaziano, J Michael ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

antioxidants; atherosclerosis; beta carotene; cardiovascular disease; coronary heart disease; vitamin C; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; VITAMIN B GROUP;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE;

EID: 0030249259     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(96)00184-0     Document Type: Article

References (59)

1. 1. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol - modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915
2. 2. Hessler JR, Morel DW, James LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983;3:215
3. 3. Yagi K. Increased serum lipid peroxides initiate atherogenesis. Bioessays 1984; 1:58
4. 4. Quinn MT, Parthasarathy S, Steinberg D. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci USA 1985;82:5949
5. 5. Schuffner T, Taylor K, Bardic EA, et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol 1980;100:57
6. 6. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181
7. 7. Fogelman AM, Schechter I, Hokom M, Child JS, Edwards PA. Malondialdehyde alteration of low density lipoproteins leads to cholesterol ester accumulation in human monocytemacrophages. Proc Natl Acad Sci USA 1980;77:2214
8. 8. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333
9. 9. Salonen T, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883
10. 10. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620
11. 11. Marcus AJ, Silk ST, Safier LB, Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 1977;59:149
12. 2. Implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun 1990;10:221
13. 13. Verlangieri AJ, Kapeghian JC, El-Dean S, Bush M. Fruit and vegetable consumption and cardiovascular disease mortality. Med Hypoth 1985;16:7
14. 14. Ginter E. Decline of coronary mortality in the United States and vitamin C. Am J Clin Nutr 1979;32:511
15. 15. Gey KF, Brubacher GB, Stahelin. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:1368
16. 16. Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989;570:254
17. 17. Gey KF, Stahelin HB, Puska P, Evans A. Relationship of plasma vitamin C to mortality from ischemic heart disease. Ann NY Acad Sci 1987;498:110
18. 18. Riemersma RA, Oliver M, Elton MA, et al. Plasma antioxidants and coronary heart disease: vitamins C and E and selenium. Eur J Clin Nutr 1990;44:143
19. 19. Riemersma RA, Wood DA, McIntyre CHH, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, E, and carotene. Lancet 1991;337:1
20. 20. Riemersma RA, Wood DA, McIntyre CHH, Elton RA, Gey KF, Oliver MF. Low plasma vitamin E and C increased risk of angina in Scottish men. Ann NY Acad Sci 1989;570:291
21. 21. Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary heart disease in man. Am J Clin Nutr 1980;33:2079
22. 22. Kardinaal AFM, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379
23. 23. Manson JE, Stampfer MJ, Willet WC, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 1991;84(suppl II): 2168.
24. 24. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. A prospective study of vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993;328:1444
25. 25. Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 1992;85:865
26. 26. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51
27. 27. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18:858
28. 28. Adams CF. Nutritive values of American foods. Washington, DC: US Department of Agriculture, 1975 (No 456)
29. 29. Consumer and Food Economics Institute. Composition of foods: fruits and fruit juices, raw, processed, prepared. Handbook 8-9. Washington, DC: US Department of Agriculture, 1982
30. 30. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17
31. 31. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Dietary intake and risk of coronary heart disease among men. N Engl J Med 1993;328:1450
32. 32. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194
33. 33. Gaziano JM, Manson JE, Branch LG, et al. Dietary beta carotene and decreased cardiovascular mortality in an elderly cohort. J Am Coll Cardiol 1992;19:377
34. 34. Lapidus L, Anderson H, Bengtson C, Bosceus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12 year follow-up of participants in the study of women in Gothenberg, Sweden. Am J Clin Nutr 1986;44:444
35. 35. Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995;273:1849
36. 36. Gey KF, Stahelin HB. Eicholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Prospective Basel Study. J Clin Invest 1993;71:3
37. 37. Eichholzer M, Stahelin HB, Gey KF. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke, respectively: 12-year follow-up of the Prospective Basel Study. In: Emerit I, Chance B, eds. Free radicals and aging. Basel, Switzerland: Birkhauser Verlag, 1992:398
38. 38. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease in the Lipid Research Clinics Coronary Primary Prevention Trial (abstract). Circulation 1993;87(2):2
39. 39. Salonen JT, Nyyssonen K, Parviainen, Kantola M, Korpela H, Salonen R. Low plasma beta carotene, vitamin E and selenium levels associated with accelerated carotid atherogenesis in hypercholesterolemic eastern Finnish men. Circulation 1993;87(2):1
40. 40. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag M. A population based case-control study of serum antioxidants and myocardial infarction. Am J Epidemiol 1991;134:719
41. 41. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9 year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462
42. 42. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am J Cardiol 1985;56:226
43. 43. Hennekens CH, Buring JE. Observational evidence. Ann NY Acad Sci, 1994, in press.
44. 44. Livingston PD, Jones C. Treatment of intermittent claudication with vitamin E. Lancet 1958;2:602
45. 45. Williams HTG, Fenna D, MacBeth RA. Alpha tocopherol in the treatment of intermittent claudication. Surg Gyn Obstet 1971; 132:662
46. 46. Haeger K. Long-time treatment of intermittent claudication with Vitamin E. Am J Clin Nutr 1974;27:1179
47. 47. Anderson TW, Reid W. A double-blind trial of vitamin E in the treatment of angina pectoris. Am Heart J 1974;93:444
48. 48. Gillilan RE, Mandell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 1977;93(4):444
49. 49. DeMaio SJ, King SB III, Lembo NJ, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992;11:131
50. 50. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483
51. 51. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994;330:1029
52. 52. Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris: a randomized, double-blind, controlled trial. JAMA 1996;275:693
53. 53. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145
54. 54. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina. Circulation 1990;82(suppl III):202
55. 55. The Steering Committee of the Physicians' Health Study. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129
56. 56. Omen GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150
57. 57. Stephens NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781
58. 58. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins - benefits not yet proven. N Engl J Med 1994;330:1080
59. 59. Steinberg D and Workshop Participants. Antioxidants in the prevention of human atherosclerosis: summary proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991. Bethesda MD. Circulation 1992;85(6):2337